SYDNEY, May 16, 2024 – FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, announced it has reached an agreement with Imtrade Australia Pty Ltd, trading as Imtrade CropScience (“Imtrade”) resolving foreshadowed patent infringement litigation against Imtrade for infringing on FMC patents relating to chlorantraniliprole.
On October 2023, FMC sent a notice letter to Imtrade for importing chlorantraniliprole into Australia, and using the imported chlorantraniliprole without FMC’s authorization. Chlorantraniliprole is FMC’s leading insecticide ingredient branded as Rynaxypyr® active and made by FMC’s patented process.
“We are pleased to reach a settlement that protects FMC’s investment in researching, developing and commercializing chlorantraniliprole,” said Michael Reilly, executive vice president, general counsel and secretary of FMC. “FMC will continue to vigorously enforce our intellectual property rights in Australia and worldwide.”
FMC maintains an extensive patent estate for its chlorantraniliprole technology in the U.S., China, India, and other important agricultural markets throughout the world. The company markets its products that contain chlorantraniliprole under several brand names around the world, including Rynaxypyr® active, Altacor®, Coragen®, Elevest®, Prevathon® and Vantacor® insect control products.
“Intellectual property rights are an essential tool for continued innovation in the crop protection market, serving the interest of farmers, customers, employees, suppliers and partners,” said Pramod Thota, vice president and president of FMC Asia Pacific. “FMC is committed to bringing farmers the latest and most innovative crop protection solutions to address their evolving needs today and in the future.”
